Home › Funds › TRUSTCO BANK CORP N Y › ABT

TRUSTCO BANK CORP N Y position in ABT

ABBOTT LABORATORIES · Health Care

TRUSTCO BANK CORP N Y reported holding 16,752 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$1.7M, representing 1.31% of its reported portfolio and ranking #21 among its reported holdings. TRUSTCO BANK CORP N Y has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)16.75K sh
Reported value held$1.66M
Portfolio Weight1.31%
First reportedQ3 2023
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How TRUSTCO BANK CORP N Y's ABT position evolved

TRUSTCO BANK CORP N Y first disclosed a stake in ABT in Q3 2023 at 21,860 shares (US$2.1M). The position peaked in Q2 2025 at 19,678 shares, worth US$2.7M. Across 13 filings, TRUSTCO BANK CORP N Y increased the stake 0 time(s), trimmed it 10 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 16,752 shares valued at US$1.7M — a reduction of -1,363 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 21.86K $2.12M New
Q4 2023 21.84K $2.40M Hold
Q1 2024 20.72K $2.36M Reduce
Q2 2024 20.64K $2.15M Hold
Q3 2024 20.49K $2.34M Reduce
Q4 2024 20.20K $2.29M Reduce
Q1 2025 19.78K $2.62M Reduce
Q2 2025 19.68K $2.68M Reduce
Q3 2025 19.43K $2.60M Reduce
Q4 2025 19.28K $2.42M Reduce
Q1 2026 18.97K $1.95M Reduce
Q2 2026 18.11K $1.64M Reduce
Q3 2026 16.75K $1.66M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.65B), Charles Schwab Investment Management (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has TRUSTCO BANK CORP N Y held ABT?

TRUSTCO BANK CORP N Y has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is TRUSTCO BANK CORP N Y's current position in ABT?

As of Q3 2026, TRUSTCO BANK CORP N Y holds 16.75K shares of ABT (ABBOTT LABORATORIES), valued at $1.66M, representing 1.31% of its reported portfolio and ranking #21.

Has TRUSTCO BANK CORP N Y been buying or selling ABT?

In the latest 13F filing (Q3 2026), TRUSTCO BANK CORP N Y reduced its position in ABT. The position peaked in Q2 2025 at 19.68K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Charles Schwab Investment Management, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.